Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 66
Filtrer
1.
Phys Rev Lett ; 125(6): 062501, 2020 Aug 07.
Article de Anglais | MEDLINE | ID: mdl-32845657

RÉSUMÉ

Precise antineutrino measurements are very sensitive to proper background characterization. We present an improved measurement of the ^{13}C(α,n)^{16}O reaction cross section which constitutes significant background for large ν[over ¯] detectors. We greatly improve the precision and accuracy by utilizing a setup that is sensitive to the neutron energies while making measurements of the excited state transitions via secondary γ-ray detection. Our results shows a 54% reduction in the background contributions from the ^{16}O(3^{-},6.13 MeV) state used in the KamLAND analysis.

2.
Phys Rev Lett ; 122(5): 052502, 2019 Feb 08.
Article de Anglais | MEDLINE | ID: mdl-30822004

RÉSUMÉ

The neutron-capture reaction plays a critical role in the synthesis of the elements in stars and is important for societal applications including nuclear power generation and stockpile-stewardship science. However, it is difficult-if not impossible-to directly measure neutron capture cross sections for the exotic, short-lived nuclei that participate in these processes. In this Letter we demonstrate a new technique which can be used to indirectly determine neutron-capture cross sections for exotic systems. This technique makes use of the (d,p) transfer reaction, which has long been used as a tool to study the structure of nuclei. Recent advances in reaction theory, together with data collected using this reaction, enable the determination of neutron-capture cross sections for short-lived nuclei. A benchmark study of the ^{95}Mo(d,p) reaction is presented, which illustrates the approach and provides guidance for future applications of the method with short-lived isotopes produced at rare isotope accelerators.

3.
Phys Rev Lett ; 117(9): 092502, 2016 Aug 26.
Article de Anglais | MEDLINE | ID: mdl-27610848

RÉSUMÉ

The ß-delayed neutron emission of ^{83,84}Ga isotopes was studied using the neutron time-of-flight technique. The measured neutron energy spectra showed emission from states at excitation energies high above the neutron separation energy and previously not observed in the ß decay of midmass nuclei. The large decay strength deduced from the observed intense neutron emission is a signature of Gamow-Teller transformation. This observation was interpreted as evidence for allowed ß decay to ^{78}Ni core-excited states in ^{83,84}Ge favored by shell effects. We developed shell model calculations in the proton fpg_{9/2} and neutron extended fpg_{9/2}+d_{5/2} valence space using realistic interactions that were used to understand measured ß-decay lifetimes. We conclude that enhanced, concentrated ß-decay strength for neutron-unbound states may be common for very neutron-rich nuclei. This leads to intense ß-delayed high-energy neutron and strong multineutron emission probabilities that in turn affect astrophysical nucleosynthesis models.

4.
Phys Rev Lett ; 114(21): 212501, 2015 May 29.
Article de Anglais | MEDLINE | ID: mdl-26066430

RÉSUMÉ

The Galactic 1.809-MeV γ-ray signature from the ß decay of ^{26g}Al is a dominant target of γ-ray astronomy, of which a significant component is understood to originate from massive stars. The ^{26g}Al(p,γ)^{27}Si reaction is a major destruction pathway for ^{26g}Al at stellar temperatures, but the reaction rate is poorly constrained due to uncertainties in the strengths of low-lying resonances in ^{27}Si. The ^{26g}Al(d,p)^{27}Al reaction has been employed in inverse kinematics to determine the spectroscopic factors, and hence resonance strengths, of proton resonances in ^{27}Si via mirror symmetry. The strength of the 127-keV resonance is found to be a factor of 4 higher than the previously adopted upper limit, and the upper limit for the 68-keV resonance has been reduced by an order of magnitude, considerably constraining the ^{26g}Al destruction rate at stellar temperatures.

5.
Phys Rev Lett ; 112(17): 172701, 2014 May 02.
Article de Anglais | MEDLINE | ID: mdl-24836240

RÉSUMÉ

Single-neutron states in (133)Sn and (209)Pb, which are analogous to single-electron states outside of closed atomic shells in alkali metals, were populated by the ((9)Be, (8)Be) one-neutron transfer reaction in inverse kinematics using particle-γ coincidence spectroscopy. In addition, the s(1/2) single-neutron hole-state candidate in (131)Sn was populated by ((9)Be, (10)Be). Doubly closed-shell (132)Sn (radioactive) and (208)Pb (stable) beams were used at sub-Coulomb barrier energies of 3 MeV per nucleon. Level energies, γ-ray transitions, absolute cross sections, spectroscopic factors, asymptotic normalization coefficients, and excited-state lifetimes are reported and compared with shell-model expectations. The results include a new transition and precise level energy for the 3p(1/2) candidate in (133)Sn, new absolute cross sections for the 1h(9/2) candidate in (133)Sn and 3s(1/2) candidate in (131)Sn, and new lifetimes for excited states in (133)Sn and (209)Pb. This is the first report on excited-state lifetimes of (133)Sn, which allow for a unique test of the nuclear shell model and (132)Sn double-shell closure.

6.
Phys Rev Lett ; 108(19): 192701, 2012 May 11.
Article de Anglais | MEDLINE | ID: mdl-23003029

RÉSUMÉ

The best examples of halo nuclei, exotic systems with a diffuse nuclear cloud surrounding a tightly bound core, are found in the light, neutron-rich region, where the halo neutrons experience only weak binding and a weak, or no, potential barrier. Modern direct-reaction measurement techniques provide powerful probes of the structure of exotic nuclei. Despite more than four decades of these studies on the benchmark one-neutron halo nucleus 11Be, the spectroscopic factors for the two bound states remain poorly constrained. In the present work, the 10Be(d,​p) reaction has been used in inverse kinematics at four beam energies to study the structure of 11Be. The spectroscopic factors extracted using the adiabatic model were found to be consistent across the four measurements and were largely insensitive to the optical potential used. The extracted spectroscopic factor for a neutron in an nℓj=2s(1/2) state coupled to the ground state of 10Be is 0.71(5). For the first excited state at 0.32 MeV, a spectroscopic factor of 0.62(4) is found for the halo neutron in a 1p(1/2) state.

7.
Phys Rev Lett ; 108(10): 102501, 2012 Mar 09.
Article de Anglais | MEDLINE | ID: mdl-22463404

RÉSUMÉ

We report on the first observation of dineutron emission in the decay of 16Be. A single-proton knockout reaction from a 53 MeV/u 17B beam was used to populate the ground state of 16Be. 16Be is bound with respect to the emission of one neutron and unbound to two-neutron emission. The dineutron character of the decay is evidenced by a small emission angle between the two neutrons. The two-neutron separation energy of 16Be was measured to be 1.35(10) MeV, in good agreement with shell model calculations, using standard interactions for this mass region.

8.
Phys Rev Lett ; 104(11): 112701, 2010 Mar 19.
Article de Anglais | MEDLINE | ID: mdl-20366470

RÉSUMÉ

Spectroscopic factors have been extracted for proton-rich 34Ar and neutron-rich 46Ar using the (p, d) neutron transfer reaction. The experimental results show little reduction of the ground state neutron spectroscopic factor of the proton-rich nucleus 34Ar compared to that of 46Ar. The results suggest that correlations, which generally reduce such spectroscopic factors, do not depend strongly on the neutron-proton asymmetry of the nucleus in this isotopic region as was reported in knockout reactions. The present results are consistent with results from systematic studies of transfer reactions but inconsistent with the trends observed in knockout reaction measurements.

9.
Phys Rev Lett ; 102(15): 152502, 2009 Apr 17.
Article de Anglais | MEDLINE | ID: mdl-19518624

RÉSUMÉ

The rate of the (17)F(p,gamma)(18)Ne reaction is important in various astrophysical events. A previous (17)F(p,p)(17)F measurement identified a 3;{+} state providing the strongest resonance contribution, but the resonance strength was unknown. We have directly measured the (17)F(p,gamma)(18)Ne reaction using a mixed beam of (17)F and (17)O at ORNL. The resonance strength for the 3;{+} resonance in (18)Ne was found to be omegagamma = 33 +/- 14(stat) +/-1 7(syst) meV, corresponding to a gamma width of Gamma_{gamma} = 56 +/- 24(stat) +/- 30(syst) meV. An upper limit on the direct capture of S(E)

10.
Phys Rev Lett ; 100(15): 152502, 2008 Apr 18.
Article de Anglais | MEDLINE | ID: mdl-18518100

RÉSUMÉ

The neutron unbound ground state of (25)O (Z=8, N=17) was observed for the first time in a proton knockout reaction from a (26)F beam. A single resonance was found in the invariant mass spectrum corresponding to a neutron decay energy of 770_+20(-10) keV with a total width of 172(30) keV. The N=16 shell gap was established to be 4.86(13) MeV by the energy difference between the nu1s(1/2) and nu0d(3/2) orbitals. The neutron separation energies for (25)O agree with the calculations of the universal sd shell model interaction. This interaction incorrectly predicts an (26)O ground state that is bound to two-neutron decay by 1 MeV, leading to a discrepancy between the theoretical calculations and experiment as to the particle stability of (26)O. The observed decay width was found to be on the order of a factor of 2 larger than the calculated single-particle width using a Woods-Saxon potential.

11.
Phys Rev Lett ; 99(11): 112501, 2007 Sep 14.
Article de Anglais | MEDLINE | ID: mdl-17930431

RÉSUMÉ

We have observed a resonance in neutron-fragment coincidence measurements that is presumably the first excited state of 23O at 2.8(1) MeV excitation energy which decays into the ground state of 22O. This interpretation is consistent with theory. The reaction mechanism supports the assignment of the observed state as the 5/2+ hole state. This assignment and the recently observed 3/2+ particle state advance the understanding of 23O.

12.
Am J Obstet Gynecol ; 184(7): 1488-94; discussion 1494-5, 2001 Jun.
Article de Anglais | MEDLINE | ID: mdl-11408872

RÉSUMÉ

OBJECTIVES: We describe a series of patients with rectal prolapse who had other pelvic floor defects. STUDY DESIGN: Patients with rectal prolapse that we examined between 1990 and 2000 were reviewed. RESULTS: During this time frame 55 patients with rectal prolapse were seen by one of us. Fifty-two of these patients had other defects of pelvic floor support and are the subject of this report. The diagnosis was established in all patients with video defecography. Thirty-nine of the patients had internal (occult) prolapse that simulated either a rectocele or an enterocele. The mean number of surgical procedures for pelvic floor support before the diagnosis of rectal prolapse was 1.5. Thirty-one patients underwent a sigmoid resection with rectopexy, 12 underwent a rectopexy alone, 3 underwent a Ripstein procedure, 2 elderly patients had physical therapy alone, and the other 4 patients had surgical correction of the rectal prolapse before being referred for repair of vaginal vault prolapse. Other procedures performed simultaneously included sacral colpopexy, sacrospinous suspension, rectopubic urethropexy, and abdominal fixation of the vagina to the uterosacral ligaments. CONCLUSIONS: Rectal prolapse frequently coexists with other pelvic floor defects. Internal rectal prolapse may simulate a rectocele or enterocele and requires defecography to establish the diagnosis. Rectopexy (with or without sigmoid resection) is a satisfactory technique for correction and may be combined with other reconstructive procedures on the pelvic floor.


Sujet(s)
Plancher pelvien/physiopathologie , Prolapsus rectal/physiopathologie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Défécographie , Diagnostic différentiel , Femelle , Hernie/imagerie diagnostique , Humains , Adulte d'âge moyen , Plancher pelvien/chirurgie , Prolapsus rectal/complications , Prolapsus rectal/imagerie diagnostique , Prolapsus rectal/thérapie , Rectocèle/imagerie diagnostique , Rectum/chirurgie , Prolapsus utérin/complications
13.
Gynecol Oncol ; 79(3): 495-8, 2000 Dec.
Article de Anglais | MEDLINE | ID: mdl-11104627

RÉSUMÉ

OBJECTIVE: This trial was undertaken to determine the dose limiting toxicity (DLT) and maximum tolerated dose (MTD) of topotecan that can be administered for 3 days q 21 days. A 3-day schedule is more convenient and less expensive than standard 5-day dosing. METHODS: Patients with recurrent epithelial ovary, tubal, or peritoneal carcinoma were treated with escalating doses of topotecan beginning at 2.50 mg/m(2) as an outpatient days 1-3 q 21 days. Colony stimulating factors were not employed prophylactically, but could be added for grade 4 marrow toxicity. RESULTS: Twenty patients with a median age of 61 (range 46-80) and performance status of 0 or 1 were entered. All patients had received at least one prior paclitaxel/platinum regimen; 6 had received two. Ninety-one cycles were delivered (median = 6) and 98.9% were on schedule. Grade 4 neutropenia was seen in 17 of 20 patients (85%) in cycle 1 and in 38 of 91 (41.8%) total cycles. Sixteen of 20 patients (80%) started G-CSF on cycle 2. Two of 91 (2.2%) cycles had grade 4 thrombocytopenia. Four cycles (4.4%) were associated with febrile neutropenia. Two patients experienced grade 4 neurotoxicity (DLT) at 4.25 mg/m(2). Other nonhematologic toxicity was mild. CONCLUSIONS: Topotecan can be safely administered on schedule as an outpatient days 1-3 q 21 days. Neurotoxicity was the DLT when G-CSF was added; the MTD was 3.75 mg/m(2). There was minimal other nonhematologic toxicity. Neutropenia was predictable and easily managed with G-CSF. Febrile neutropenia was uncommon and thrombocytopenia was rare at the doses evaluated.


Sujet(s)
Antinéoplasiques/effets indésirables , Tumeurs de la trompe de Fallope/traitement médicamenteux , Récidive tumorale locale/traitement médicamenteux , Tumeurs de l'ovaire/traitement médicamenteux , Tumeurs du péritoine/traitement médicamenteux , Topotécane/effets indésirables , Sujet âgé , Sujet âgé de 80 ans ou plus , Antinéoplasiques/administration et posologie , Relation dose-effet des médicaments , Calendrier d'administration des médicaments , Antienzymes/administration et posologie , Antienzymes/effets indésirables , Épithélium/anatomopathologie , Femelle , Facteur de stimulation des colonies de granulocytes/usage thérapeutique , Hémopathies/induit chimiquement , Hémopathies/traitement médicamenteux , Humains , Perfusions veineuses , Infections à Klebsiella/induit chimiquement , Klebsiella pneumoniae , Adulte d'âge moyen , Phases du sommeil/effets des médicaments et des substances chimiques , Topotécane/administration et posologie
14.
J Hazard Mater ; 79(1-2): 189-208, 2000 Dec 01.
Article de Anglais | MEDLINE | ID: mdl-11040395

RÉSUMÉ

For a limiting case of thermodynamic equilibrium, the importance of two classes of thermal chemical reactions that modify the structure and bioactivity of polycyclic aromatic hydrocarbons (PAH) was assessed computationally. These reactions are molecular weight (MW) growth by acetylene addition, and intramolecular rearrangement (isomerization). Temperatures (300-1100 degrees C), and the chemical environment (C(2)H(2)/H(2) molar ratios) were selected for relevancy to thermal treatment of PAH-contaminated soils under oxygen-free conditions. Molecular mechanics methods [MM3(92)] were used to compute thermochemical properties for calculation of equilibrium constants, i.e., heats of formation, standard entropies, and heat capacities for 30 PAH with empirical formulae C(14)H(10), C(16)H(10), C(18)H(10), C(18)H(12), C(20)H(10), and C(20)H(12). Included were 11 PAH containing only six-membered rings and 19 PAH containing both five- and six-membered rings. For each of these PAH the calculations predict that with increasing temperature, isomerization increases the "complexity" of the PAH mixture, i.e., the relative abundance of each PAH isomer in the mixture other than the most stable isomer, increases. Isomerization also partially transforms non-mutagens to mutagens, e.g., pyrene and benzo[e]pyrene to fluoranthene and benzo[a]pyrene, respectively, and partially converts cyclopenta[c, d]pyrene (CPEP) and chrysene, both human cell mutagens, to one and three additional human cell mutagens, respectively. Acetylene addition transforms the non-mutagens phenanthrene and pyrene to the mutagens triphenylene and CPEP, respectively. Some of the predicted PAH have been observed elsewhere among the products of aromatics pyrolysis. This study elucidates PAH reactivity for comparison with measurements, and identifies PAH reactions to be monitored and avoided in soil thermal decontamination and other waste remediation processes.


Sujet(s)
Hydrocarbures aromatiques polycycliques/pharmacocinétique , Polluants du sol/pharmacocinétique , Modèles théoriques , Thermodynamique
15.
Environ Health Perspect ; 108(8): 709-17, 2000 Aug.
Article de Anglais | MEDLINE | ID: mdl-10964790

RÉSUMÉ

In this paper we report yields, identities, and mutagenicities of products from heating a polycyclic aromatic hydrocarbon (PAH)-contaminated, Superfund-related synthetic soil matrix without exogenous oxygen. We heated batch samples of soil pretreated with 5.08 wt% (by weight) pyrene in a tubular furnace under a constant flow of helium gas at 250, 500, 750, and 1,000 +/- 20 degrees C. Dichloromethane (DCM) extracts of cooled residues of heated soil and of volatiles condensed on a cold finger after 1 sec residence time at furnace temperature were assayed gravimetrically and analyzed for PAH by HPLC, HPLC coupled to mass spectrometry, and gas chromatography coupled to mass spectrometry. All four temperatures volatilized pyrene and generated other PAHs, including alkylated pyrenes. We detected bioactive PAHs in the product volatiles: cyclopenta[cd]pyrene (CPP) at 750 and 1,000 degrees C and benzo[a]pyrene (BaP) at 1,000 degrees C. We found a clean soil residue, i.e., no pyrene or other DCM extracts, only at 750 degrees C. Control experiments with uncontaminated soil, pyrene, and Ottawa sand plus 4.89 wt% pyrene revealed no CPP or BaP production from soil itself, but these experiments imply that pyrene interactions with soil, e.g., soil-bound silica, stimulate CPP and BaP production. We detected mutagenicity to human diploid lymphoblasts (in vitro) in volatiles from 1,000 degrees C heating of soil plus pyrene and sand plus pyrene, and in the residue from 500 degrees C heating of soil plus pyrene. Three plausible pathways for pyrene conversion to other PAHs are a) a reaction with light gas species, e.g., soil- or pyrene-derived acetylene; b) loss of C(2)-units followed by reaction with a PAH; and c) dimerization with further molecular weight growth via cyclodehydrogenation. This study shows that thermal treatment of PAH-polluted soil may generate toxic by-products that require further cleanup by oxidation or other measures.


Sujet(s)
Décontamination , Hydrocarbures aromatiques polycycliques/composition chimique , Pyrènes/composition chimique , Polluants du sol , Benzopyrènes/composition chimique , Cellules cultivées , Chromatographie en phase liquide à haute performance , Décontamination/méthodes , Chromatographie gazeuse-spectrométrie de masse , Température élevée , Humains , Tests de mutagénicité
16.
J Clin Oncol ; 18(8): 1606-13, 2000 Apr.
Article de Anglais | MEDLINE | ID: mdl-10764420

RÉSUMÉ

PURPOSE: To determine whether the addition of cisplatin-based chemotherapy (CT) to pelvic radiation therapy (RT) will improve the survival of early-stage, high-risk patients with cervical carcinoma. PATIENTS AND METHODS: Patients with clinical stage IA(2), IB, and IIA carcinoma of the cervix, initially treated with radical hysterectomy and pelvic lymphadenectomy, and who had positive pelvic lymph nodes and/or positive margins and/or microscopic involvement of the parametrium were eligible for this study. Patients were randomized to receive RT or RT + CT. Patients in each group received 49.3 GY RT in 29 fractions to a standard pelvic field. Chemotherapy consisted of bolus cisplatin 70 mg/m(2) and a 96-hour infusion of fluorouracil 1,000 mg/m(2)/d every 3 weeks for four cycles, with the first and second cycles given concurrent to RT. RESULTS: Between 1991 and 1996, 268 patients were entered onto the study. Two hundred forty-three patients were assessable (127 RT + CT patients and 116 RT patients). Progression-free and overall survival are significantly improved in the patients receiving CT. The hazard ratios for progression-free survival and overall survival in the RT only arm versus the RT + CT arm are 2.01 (P =.003) and 1.96 (P =. 007), respectively. The projected progression-free survivals at 4 years is 63% with RT and 80% with RT + CT. The projected overall survival rate at 4 years is 71% with RT and 81% with RT + CT. Grades 3 and 4 hematologic and gastrointestinal toxicity were more frequent in the RT + CT group. CONCLUSION: The addition of concurrent cisplatin-based CT to RT significantly improves progression-free and overall survival for high-risk, early-stage patients who undergo radical hysterectomy and pelvic lymphadenectomy for carcinoma of the cervix.


Sujet(s)
Tumeurs du col de l'utérus/thérapie , Adulte , Sujet âgé , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Cisplatine/administration et posologie , Association thérapeutique , Évolution de la maladie , Femelle , Fluorouracil/administration et posologie , Humains , Hystérectomie , Lymphadénectomie , Adulte d'âge moyen , Pelvis/effets des radiations , Dosimétrie en radiothérapie , Radiothérapie adjuvante , Taux de survie , Tumeurs du col de l'utérus/mortalité , Tumeurs du col de l'utérus/radiothérapie , Tumeurs du col de l'utérus/chirurgie
17.
Aliment Pharmacol Ther ; 13(9): 1215-9, 1999 Sep.
Article de Anglais | MEDLINE | ID: mdl-10468704

RÉSUMÉ

AIM: To compare the pharmacokinetics of lansoprazole in patients with reflux oesophagitis and in healthy volunteers, after a single dose and at steady-state. PATIENTS AND METHODS: A 30 mg dose of lansoprazole was administered orally daily for 7 days in eight healthy male volunteers aged 21-24 years, and in 16 patients aged 29-65 years with grade 2 or 3 reflux oesophagitis. The pharmacokinetics were assessed over the 24 h dose interval following the first dose and again after the 7th dose. RESULTS: Within both the patient and volunteers groups, there were no significant differences between day 1 and day 7 in any of the pharmacokinetic parameters including maximum concentration (Cmax), area under the concentration-time curve (AUC), and terminal half-life of elimination (t(1/2)). However, on both days 1 and 7, values were significantly higher in the patients than in the healthy volunteers. On day 7, Cmax was 1343 ng/mL in patients compared with 765 ng/mL in healthy volunteers, AUC was 3458 ng.h/mL vs. 1350 ng.h/mL and t(1/2) was 1.62 h vs. 0.90 h. CONCLUSION: The differences in results for the pharmacokinetics reflect reduced lansoprazole clearance in the patient group. Other research has not found a difference in pharmacokinetics when comparing healthy volunteers with patients with acid-related disorders. The difference in lansoprazole clearance in this study may be related to a variety of factors that are different in patients compared with young normal volunteers, such as age, gender, other drugs, and reduced general well-being.


Sujet(s)
Antiulcéreux/pharmacocinétique , Antienzymes/pharmacocinétique , Oesophagite peptique/métabolisme , Oméprazole/analogues et dérivés , Inhibiteurs de la pompe à protons , (Pyridin-2-ylméthyl)sulfinyl-1H-benzimidazoles , Adulte , Antiulcéreux/administration et posologie , Antiulcéreux/sang , Aire sous la courbe , Chromatographie en phase liquide à haute performance , Calendrier d'administration des médicaments , Antienzymes/administration et posologie , Antienzymes/sang , Oesophagite peptique/traitement médicamenteux , Femelle , Humains , Lansoprazole , Modèles linéaires , Mâle , Adulte d'âge moyen , Oméprazole/administration et posologie , Oméprazole/sang , Oméprazole/pharmacocinétique , Valeurs de référence
18.
J Hazard Mater ; 64(3): 295-311, 1999 Feb 15.
Article de Anglais | MEDLINE | ID: mdl-10337399

RÉSUMÉ

To determine decontamination behavior as affected by temperature, shallow beds of a clay-rich, a calcerous, and a sedimentary soil, artificially polluted with hexachlorobenzene, 4-chlorobiphenyl, naphthalene, or n-decane, were separately heated at 5 degrees C min-1 in a thermogravimetric analyzer. Temperatures for deep cleaning of the calcerous and the sedimentary soil increased with increasing boiling point (bp) of the aromatic contaminants, but removal efficiencies still approached 100% well below the bp. Decontamination rates were therefore modelled according to a pollutant evaporation-diffusion transport model. For the calcerous and sedimentary soils, this model reasonably correlated removal of roughly the first 2/3 of the naphthalene, but gave only fair predictions for hexachlorobenzene and 4-chlorobiphenyl. It was necessary to heat the clay soil above the aromatics bp to achieve high decontamination efficiencies. Weight loss data imply that for temperatures from near ambient to as much as 150 degrees C, interactions of each aromatic with the clay soil, or its decomposition products, result in lower net volatilization of the contaminated vs. neat clay. A similar effect was observed in heating calcerous soil polluted with hexachlorobenzene from near ambient to about 140 degrees C. Decontamination mechanisms remain to be established, although the higher temperatures needed to remove aromatics from the clay may reflect a more prominent role for surface desorption than evaporation. This would be consistent with our estimates that the clay can accommodate all of the initial pollutant loadings within a single surface monolayer, whereas the calcerous and sedimentary soils cannot.


Sujet(s)
Alcanes/métabolisme , Dérivés du biphényle/métabolisme , Décontamination/méthodes , Fongicides industriels/métabolisme , Déchets dangereux/prévention et contrôle , Hexachloro-benzène/métabolisme , Température élevée , Naphtalènes/métabolisme , Polluants du sol/métabolisme , Sol/analyse , Diffusion , Humains , Température , Thermogravimétrie
19.
Am J Pathol ; 154(3): 945-50, 1999 Mar.
Article de Anglais | MEDLINE | ID: mdl-10079273

RÉSUMÉ

Distinction of malignant uterine leiomyosarcomas from benign leiomyomas by morphological criteria is not always possible. Leiomyosarcomas typically have complex cytogenetic abnormalities; in contrast, leiomyomas have simple or no cytogenetic abnormalities. To understand better the biological distinction(s) between these tumors, we analyzed two other potential markers of genomic instability, loss of heterozygosity (LOH) and microsatellite instability. We examined archival materials from 16 leiomyosarcomas and 13 benign leiomyomas by polymerase chain reaction for 26 microsatellite polymorphisms. Markers were selected based on previous reports of cytogenetic or molecular genetic abnormalities in leiomyosarcomas or leiomyomas and surveyed chromosomes 7, 9, 10, 11, 12, 14, 15, 16, 18, 21, and X. LOH for markers on chromosomes 15, 18, 21, and X was infrequent in leiomyosarcomas (1 of 6 tumors for each chromosome) and not observed for markers on chromosomes 7, 9, 11, 12, 14, or 16. Interestingly, 8 of 14 (57.2%) informative leiomyosarcomas had LOH for at least one marker on chromosome 10 and involved both chromosomal arms in 45.5% (5 of 11). In contrast to leiomyosarcomas, LOH for chromosome 10 was not found in 13 benign leiomyomas. Microsatellite instability was found infrequently in leiomyosarcomas and not detected in leiomyoma. Clinicopathological features (eg, atypia, necrosis, and clinical outcome) did not appear to correlate with LOH for chromosome 10. In contrast to other chromosomes studied, LOH on chromosome 10 was frequent in leiomyosarcomas and absent in benign leiomyomas.


Sujet(s)
Chromosomes humains de la paire 10/génétique , Léiomyome/génétique , Léiomyosarcome/génétique , Perte d'hétérozygotie/génétique , Tumeurs de l'utérus/génétique , Adulte , Sujet âgé , Femelle , Humains , Répétitions microsatellites/génétique , Adulte d'âge moyen , Pronostic
20.
Environ Health Perspect ; 106 Suppl 4: 1097-107, 1998 Aug.
Article de Anglais | MEDLINE | ID: mdl-9703498

RÉSUMÉ

Effects of temperature (400-1000 degrees C) and rate of heating to 550 degrees C (100, 1000, 5000 degrees C/sec) on reduction of pyrene contamination in a Superfund-related soil and on yields of volatile products (tars, CO, CO2, methane, acetylene, ethylene) have been measured. Fifty (+/- 3)-milligram thin layers (less than or equal to 150 micron) of 63- to 125-micron soil particles, neat (i.e., without exogenous chemicals), or pretreated with 4.75 wt% of pyrene, were heated for about 1 to 6 sec, under 3 psig (pounds per in.(2) gauge) of helium in a 12-liter sealed chamber. Pyrene removal, defined as the difference in weight loss of neat versus contaminated soil, was virtually immune to heating rate but increased strongly with increasing temperature, approaching 100% at about 530 degrees C. However, for pyrenepolluted soil, excess soil weight loss and modified CO yields were observed above about 500 degrees C for a 1000 degrees C/sec heating rate. These observations suggest that soil chemical reactions with pyrene or pyrene decomposition products augment soil volatilization. Consequently at elevated temperatures, the difference in weight loss protocol may overestimate polycyclic aromatic hydrocarbon (PAH) removal from soil. Increasing heating rate caused yields of CO, CO(2), and acetylene from pyrene-polluted soil to pass through maxima. Heating neat or contaminated soil resulted in at least two gaseous products of particular environmental interest:acetylene, a precursor to PAH in thermal synthesis, and CO, a toxin to human hemoglobin.


Sujet(s)
Déchets dangereux , Santé publique , Pyrènes/métabolisme , Polluants du sol/métabolisme , Température , Acétylène/effets indésirables , Acétylène/métabolisme , Monoxyde de carbone/effets indésirables , Monoxyde de carbone/métabolisme , Humains , Pyrènes/effets indésirables , Polluants du sol/effets indésirables , Volatilisation
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...